Receptor-Specific Targeting Mediated by the Coexpression of a Targeted Murine Leukemia Virus Envelope Protein and a Binding-Defective Influenza Hemagglutinin Protein
- 1 March 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 12 (4) , 323-332
- https://doi.org/10.1089/10430340150503957
Abstract
The entry of retroviral vectors into cells requires two events: binding to a cell surface receptor and the subsequent fusion of viral and cellular membranes. The host range of a vector is therefore determined largely by the receptor specificity of the fusion protein contained in the outer viral envelope. Previous attempts to generate targeted retroviral vectors have included the addition of targeting ligands to the murine leukemia virus envelope protein (MuLV Env). Although such proteins frequently display modified cell-binding characteristics, the interaction with the targeted receptors fails to trigger virus–cell fusion. Here, we report the use of a binding-defective but fusion-competent hemagglutinin (HA) protein to complement the fusion defect in a chimeric MuLV Env targeted to the Flt-3 receptor. Retroviral vectors containing both proteins showed enhanced transduction of cells expressing Flt-3, which was abrogated by preincubating the target cells with soluble Flt-3 ligand. Furthermore, the fusion function of HA was absolutely required. These data demonstrate that it is possible to separate the binding and fusion events of retroviral entry, using two separate proteins, and suggest that varying the binding protein component in this scheme may allow a general strategy for targeting retroviral vectors.Keywords
This publication has 27 references indexed in Scilit:
- Antigen-specific membrane fusion mediated by the haemagglutinin protein of influenza A virus: separation of attachment and fusion functions on different moleculesGene Therapy, 1999
- Targeting Retroviral Vectors to CD34-Expressing Cells: Binding to CD34 Does Not Catalyze Virus-Cell FusionHuman Gene Therapy, 1999
- Retroviral Vector Targeting Human Cells via c-Kit–Stem Cell Factor InteractionHuman Gene Therapy, 1998
- Retroviral Vector Targeting to Melanoma Cells by Single-Chain Antibody Incorporation in EnvelopeHuman Gene Therapy, 1998
- Regulatory Roles of the Ligand for Flk2/Flt3 Tyrosine Kinase Receptor on Human HematopoiesisThe International Journal of Cell Cloning, 1996
- International Journal of HematologyInternational Journal of Hematology, 1995
- A transient three-plasmid expression system for the production of high titer retroviral vectorsNucleic Acids Research, 1995
- Tissue-Specific Targeting of Retroviral Vectors Through Ligand-Receptor InteractionsScience, 1994
- Paramyxovirus Fusion: A Hypothesis for ChangesVirology, 1993
- Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-RVirology, 1992